Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)

Market Cap	292.20M -6.4%
Revenue (ttm)	365.12M -1.0%
Net Income	25.03M -6.2%
EPS	0.18 -6.2%
Shares Out	141.84M
PE Ratio	11.67
Forward PE	n/a
Dividend	0.08 (3.88%)
Ex-Dividend Date	Dec 12, 2025

Volume	12,800
Average Volume	22,515
Open	2.070
Previous Close	2.060
Day's Range	2.060 - 2.070
52-Week Range	1.980 - 2.330
Beta	0.03
RSI	44.08
Earnings Date	May 22, 2026

About KLSE:YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also m...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 1,381
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: YSPSAH

Financial Performance

In 2025, KLSE:YSPSAH's revenue was 365.12 million, a decrease of -0.96% compared to the previous year's 368.66 million. Earnings were 25.03 million, a decrease of -6.21%.